❌

Normal view

Received — 30 September 2026 ⏭

Clues to Why a Breakthrough Pancreatic Cancer Drug Eventually Stops Working

✇NYT: Science
By: Gina Kolata
30 September 2026 at 13:48
Researchers are asking why patients, like former Senator Ben Sasse, inevitably develop resistance to the drug daraxonrasib.

© T.J. Kirkpatrick for The New York Times

Researchers are studying why patients, like former Senator Ben Sasse, eventually develop resistance to the drug daraxonrasib.
❌